Oral biologics & biosimilars market to reach $24.69 billion by 2030 at 21.6% cagr, driven by rising prevalence of chronic diseases.
Read More
Oral biologics & biosimilar drugs market to reach $17.17 billion by 2030 at 13.3% cagr, driven by rising prevalence of chronic diseases.
Read More
The global oral antidiabetic drugs market to reach $92.64 billion by 2030 at 6.7% cagr, driven by increasing type 2 diabetes.
Read More
The global opioids market to reach $28.59 billion by 2030 at 3.8% cagr, driven by increasing prevalence of chronic diseases.
Read More
Ophthalmic drugs market to reach $61.21 billion by 2030 at 7.9% cagr, driven by increase in the prevalence of ophthalmic disorders.
Read More
Oncology precision medicine market to reach $226.55 billion by 2030 at 12.5% cagr, driven by growing prevalence of cancer.
Read More
Oncology clinical trials market to reach $20.4 billion by 2030 at 6.3% cagr, driven by increasing cancer incidence.
Read More
Oncology biosimilars market to reach $21.28 billion by 2030 at 13.5% cagr, driven by expiration of patents of biologics used for cancer treatment.
Read More
Oncology adjuvants market to reach $2.54 billion by 2030 at 7.9% cagr, driven by increasing demand for personalized medicine.
Read More
Oncogene inhibitor market to reach $65.45 billion by 2030 at 8.6% cagr, driven by increase in the prevalence of cancer.
Read More